The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease is characterized by a widespread functional disturbance of the human brain. Fibrillar amyloid proteins are deposited inside neurons as neurofibrillary tangles and extracellularly as amyloid plaque cores and in blood vessels. The major protein subunit (A4) of the amyloid fibril of tangles, plaques and blood vessel deposits is an insoluble, highly aggregating small polypeptide of relative molecular mass 4,500. The same polypeptide is also deposited in the brains of aged individuals with trisomy 21 (Down's syndrome). We have argued previously that the A4 protein is of neuronal origin and is the cleavage product of a larger precursor protein. To identify this precursor, we have now isolated and sequenced an apparently full-length complementary DNA clone coding for the A4 polypeptide. The predicted precursor consists of 695 residues and contains features characteristic of glycosylated cell-surface receptors. This sequence, together with the localization of its gene on chromosome 21, suggests that the cerebral amyloid deposited in Alzheimer's disease and aged Down's syndrome is caused by aberrant catabolism of a cell-surface receptor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Molecular imaging studies such as those using amyloid positron emission tomography (PET) have shown that Aβ deposition reaches a plateau before brain atrophy can be identified from structural magnetic resonance imaging (MRI) and cognitive symptoms [15, 19].”
From Clinical trials of new drugs for Alzheimer disease (2020) · cites this paper as [15]
In the citing paper
“All the mutant genes of hereditary, autosomal, and dominant familial AD, including amyloid precursor protein (APP), presenilin 1, and presenilin 2, encode the major proteins involved in amyloid metabolism [14–16].”
From Clinical trials of new drugs for Alzheimer disease (2020) · cites this paper as [15]
In the citing paper
“Amyloid  protein (A), the principal protein in the senile plaques of Alzheimer's disease (AD), is an ϳ4 kDa secreted polypeptide”
From Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease (2001) · cites this paper as Kang et al., 1987
In the citing paper
“APP isoforms are encoded by several alternatively spliced transcripts (Kang et al., 1987;K itaguchi et al., 1988;Ponte et al., 1988;Tanzi et al., 1988;Golde et al., 1990;Ko ¨nig et al., 1992).”
From Alzheimer Amyloid Protein Precursor in the Rat Hippocampus: Transport and Processing through the Perforant Path (1998) · cites this paper as Kang et al., 1987
In the citing paper
“APP, first identified by Kang et al. [18], is a type I transmembrane protein with a long luminal N-terminal domain and a small cytoplasmic C-terminal tail [18,19].”
From Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations (2024) · cites this paper as [18]
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Detection of specific sequences among DNA fragments separated by gel electrophoresis
Southern, E. M. (1975) · Journal of Molecular Biology · doi:10.1016/s0022-2836(75)80083-0 · Cited by 32,249
Rigby, P. W. J., Dieckmann, M., Rhodes, C., & Berg, P. (1977) · Journal of Molecular Biology · doi:10.1016/0022-2836(77)90052-3 · Cited by 11,401
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.
Thomas, P. S. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5201 · Cited by 8,156
Aviv, H., & Leder, P. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.6.1408 · Cited by 6,751
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Self-citationLehrach, H., Diamond, D., Wozney, J. M., & Boedtker, H. (1977) · Biochemistry · doi:10.1021/bi00640a033 · Cited by 3,415
A gas-liquid solid phase peptide and protein sequenator.
Hewick, R. M., Hunkapiller, M. W., Hood, L. E., & Dreyer, W. J. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43377-7 · Cited by 2,218
Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91209-9 · Cited by 1,693
A cellular gene encodes scrapie PrP 27-30 protein
Oesch, B., Westaway, D., Wälchli, M., McKinley, M. P., Kent, S. B. H., Aebersold, R., Barry, R. A., Tempst, P., Teplow, D. B., Hood, L. E., et al. (1985) · Cell · doi:10.1016/0092-8674(85)90333-2 · Cited by 1,513
Research works printed but not linked: 4
- Alzheimer, A. Allg. Z. Psychiat. 64, 146–148 (1907).
- Katzman, R. (ed.) Biological Aspects of Alzheimer's Disease (Banbury Report 15) (Cold Spring Harbor Laboratory, New York, 1983).
- Beyreuther, K. et al. in Discussions in Neuroscience Vol. 3 (eds Bignami, A., Bolis, L. & Gajdusek, D. C. 68–79 Fondation pour I'Étude du Système Nerveux, Geneva (1986).
- Goldgaber, D., Lerman, M. I., McBride, W. O., Sallow, V. & Gajdusek, D. C. Science (in the press).
Cited by
Items 801–900 of 1,071
Amyloid β protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease
Tamaoka, A., Sawamura, N., Fukushima, T., Shoji, S., Matsubara, E., Shoji, M., Hirai, S., Furiya, Y., Endoh, R., & Mori, H. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00314-0 · Cited by 157
Benowitz, L. I., Rodriguez, W. R., Paskevich, P. A., Mufson, E. J., Schenk, D., & Neve, R. L. (1989) · Experimental Neurology · doi:10.1016/0014-4886(89)90156-8 · Cited by 142
Nimmrich, V., & Ebert, U. (2009) · Reviews in the Neurosciences · doi:10.1515/revneuro.2009.20.1.1 · Cited by 139
Sastre, M., Turner, R. S., & Levy, E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22351 · Cited by 139
Neve, R. L., McPhie, D. L., & Chen, Y. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02869-9 · Cited by 160
“’ [49].”
β‐Amyloid precursor epitopes in muscle fibers of inclusion body myositis
Askanas, V., Alvarez, R. B., & Engel, W. K. (1993) · Annals of Neurology · doi:10.1002/ana.410340408 · Cited by 140
Fraser, P. E., Nguyen, J. T., McLachlan, D. R., Abraham, C. R., & Kirschner, D. A. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03568.x · Cited by 139
Fogel, H., Frere, S., Segev, O., Bharill, S., Shapira, I., Gazit, N., O’Malley, T., Slomowitz, E., Berdichevsky, Y., Walsh, D. M., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.024 · Cited by 138
“receptor dimerization? Although the APP structure is reminiscent of other cell-surface receptors involved in signal transduction (Kang et al., 1987), the role of APP as a bona fide surface receptor has remained speculative.”
BackgroundInfluentialAmyloid precursor protein and its homologues: a family of proteolysis-dependent receptors
Jacobsen, K. T., & Iverfeldt, K. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0020-8 · Cited by 172
Golabek, A. A., Soto, C., Vogel, T., & Wisniewski, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10602 · Cited by 138
Chyung, A. S. C., Greenberg, B. D., Cook, D. G., Doms, R. W., & Lee, V. M.-Y. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.3.671 · Cited by 114
“Of the three major A b -containing isoforms encoded by the APP gene (i.e., APP695, APP751, and APP770; Kang et al., 1987; Kitaguchi et al., 1988; Ponte et al., 1988; Tanzi et al., 1988), APP695 is expressed almost exclusively by neurons of the central and peripheral nervous systems (Golde et al.”
InfluentialAleshkov, S., Abraham, C. R., & Zannis, V. I. (1997) · Biochemistry · doi:10.1021/bi9626362 · Cited by 138
Biochemistry and Molecular Biology of Amyloid β‐Protein and the Mechanism of Alzheimer's Disease
(2008) · Handbook of Clinical Neurology · doi:10.1016/s0072-9752(07)01223-7 · Cited by 137
“Neuritic (senile) plaques contain extracellular deposits of the amyloid b-proteins (Ab) (Glenner and Wong, 1984b; Kang et al., 1987) surrounded by dystrophic axons and dendrites, activated microglia and reactive astrocytes.”
BackgroundTwenty years of Alzheimer’s disease‐causing mutations
Goate, A., & Hardy, J. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07575.x · Cited by 137
“The gene encoding the Ab sequence was cloned three years later and was indeed localised to chromosome 21 (Goldgaber et al. 1987; Kang et al. 1987; Robakis et al. 1987).”
BackgroundThe role of intracellular zinc release in aging, oxidative stress, and Alzheimer’s disease
McCord, M. C., & Aizenman, E. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00077 · Cited by 136
“Amyloid plaques are comprised primarily of β amyloid (Aβ), a∼40 amino acid long peptide generated through cleavage of the amyloid precursor protein (APP; Kang et al., 1987).”
BackgroundAtwood, C., Martins, R. N., Smith, M. A., & Perry, G. L. (2002) · Peptides · doi:10.1016/s0196-9781(02)00070-0 · Cited by 175
Hilbich, C., Mönning, U., Grund, C., Masters, C. L., & Beyreuther, K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74350-6 · Cited by 137
Self-citationChen, Y., McPhie, D. L., Hirschberg, J., & Neve, R. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8929 · Cited by 137
Licastro, F., Masliah, E., Pedrini, S., & Thal, L. J. (2000) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017209 · Cited by 136
Glutamatergic synapses in neurodevelopmental disorders
Moretto, E., Murru, L., Martano, G., Sassone, J., & Passafaro, M. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.09.014 · Cited by 136
“Indeed, the amyloidprecursor protein (APP) is overexpressed in DS patients due to the presence of its encoding gene on human chromosome 21 (Kang et al., 1987).”
BackgroundStructure and function of amyloid in Alzheimer's disease
Morgan, C., Colombres, M., Núñez, M. T., & Inestrosa, N. C. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.10.004 · Cited by 172
“1C) and allowed the isolation of cDNA for the precursor protein of Ab (APP) (Goldgaber et al., 1987; Kang et al., 1987; Robakis et al., 1987; Tanzi et al., 1987).”
BackgroundHeparin-binding Properties of the Amyloidogenic Peptides Aβ and Amylin
Watson, D. J., Lander, A. D., & Selkoe, D. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31617 · Cited by 136
Du, Y. (2003) · Brain · doi:10.1093/brain/awg191 · Cited by 136
Yamazaki, T., Koo, E. H., & Selkoe, D. J. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.5.999 · Cited by 112
Lee, J.-Y., Mook-Jung, I., & Koh, J.-Y. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-j0002.1999 · Cited by 136
Haga, S., Ikeda, K., Sato, M., & Ishii, T. (1993) · Brain Research · doi:10.1016/0006-8993(93)91698-r · Cited by 145
Yuan, J., Venkatraman, S., Zheng, Y., McKeever, B. M., Dillard, L. W., & Singh, S. B. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301659n · Cited by 135
Guilloreau, L., Damian, L., Coppel, Y., Mazarguil, H., Winterhalter, M., & Faller, P. (2006) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-006-0154-1 · Cited by 151
Connelly, L. S., Jang, H., Arce, F. T., Capone, R. F., Kotler, S. A., Ramachandran, S., Kagan, B. L., Nussinov, R., & Lal, R. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp2108126 · Cited by 138
Metal exposure and Alzheimer’s pathogenesis
Liu, G., Huang, W., Moir, R. D., Vanderburg, C. R., Lai, B., Peng, Z., Tanzi, R. E., Rogers, J. T., & Huang, X. (2006) · Journal of Structural Biology · doi:10.1016/j.jsb.2005.12.011 · Cited by 135
Araki, Y., Tomita, S., Yamaguchi, H., Miyagi, N., Sumioka, A., Kirino, Y., & Suzuki, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306024200 · Cited by 122
Evert, B. O., Vogt, I. R., Kindermann, C., Ozimek, L., de Vos, R. A. I., Brunt, E. R. P., Schmitt, I., Klockgether, T., & Wüllner, U. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05389.2001 · Cited by 134
“, 1988), an integral membrane protein that is ubiquitously and abundantly expressed in neurons (Kang et al., 1987).”
BackgroundKuentzel, S. L., Ali, S. M., Altman, R. A., Greenberg, B. D., & Raub, T. J. (1993) · Biochemical Journal · doi:10.1042/bj2950367 · Cited by 116
Olsson, A., Höglund, K., Sjögren, M. J. C., Andreasen, N., Minthon, L., Lannfelt, L., Büerger, K., Möller, H., Hampel, H. J., Davidsson, P., et al. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00027-x · Cited by 151
ATP‐binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro
Chan, S. L., Kim, W. S., Kwok, J. B., Hill, A. F., Cappai, R., Rye, K., & Garner, B. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05433.x · Cited by 133
“…appears to play a particularly important role in the modulation of enzymatic processing of the amyloid precursor protein (APP) which may be sequentially cleaved by b- and csecretase to generate b-amyloid (Ab) peptides of 39–42 amino acids (Kang et al. 1987; Simons et al. 1998; Runz et al. 2002).”
BackgroundAmyloid β: linking synaptic plasticity failure to memory disruption in Alzheimer’s disease
Ma, T., & Klann, E. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07506.x · Cited by 132
“Ab-induced memory impairment It has been revealed that Ab is derived from amyloid precursor protein (APP) via abnormal sequential cleavage by b- and c-secretases (Kang et al. 1987; Esch et al. 1990; Selkoe 1998).”
BackgroundArendt, T., Holzer, M., Fruth, R., Brückner, M. K., & Gärtner, U. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00347-l · Cited by 139
Microglial activation in early stages of amyloid β protein deposition
Sasaki, A., Yamaguchi, H., Ogawa, A., Sugihara, S., & Nakazato, Y. (1997) · Acta Neuropathologica · doi:10.1007/s004010050713 · Cited by 132
“A β is derived from a larger membrane-bound protein, amyloid β protein precursor (APP) [ 11 ].”
BackgroundKar, S., Seto, D., Gaudreau, P., & Quirion, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-03-01034.1996 · Cited by 132
“This peptide is generated by the proteolytic cleavage of the A/3 precursor protein (APP), a transmembrane glycoprotein that exists as multiple isoforms resulting from the alternative splicing of a single transcript (Kang et al., 1987; Selkoe, 1993; Nitsch and Growdon, 1994).”
Ghiso, J., Rostagno, A., Gardella, J. E., Liem, L., Gorevic, P. D., & Frangione, B. (1992) · Biochemical Journal · doi:10.1042/bj2881053 · Cited by 132
Stone, J. R., Singleton, R. H., & Povlishock, J. T. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02485-9 · Cited by 132
van den Heuvel, C., Blumbergs, P., Finnie, J. W., Manavis, J., Jones, N. R., Reilly, P. L., & Pereira, R. A. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7150 · Cited by 136
CELLULAR AND MOLECULAR BIOLOGY OF ALZHEIMER'S DISEASE AND ANIMAL MODELS
Price, M. D., & Sisodia, P. D. (1994) · Annual Review of Medicine · doi:10.1146/annurev.med.45.1.435 · Cited by 132
Alzheimer disease and platelets: how’s that relevant
Catricala, S., Torti, M., & Ricevuti, G. (2012) · Immunity & Ageing · doi:10.1186/1742-4933-9-20 · Cited by 130
Pathophysiology of Alzheimer's Disease
Imbimbo, B. P., Lombard, J., & Pomara, N. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.09.009 · Cited by 152
“[129] Kang J, Lemaire HG, Unterbeck A, et al.”
BackgroundPeng, Y., Sun, J., Hon, S. M., Nylander, A., Xia, W., Feng, Y., Wang, X., & Lemere, C. A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0340-10.2010 · Cited by 143
“A is derived by proteolysis of an integral membrane protein known as the amyloid precursor protein (APP) (Kang et al., 1987).”
BackgroundPignataro, P., Dicarlo, M., Zerlotin, R., Zecca, C., Dell’Abate, M. T., Buccoliero, C., Logroscino, G., Colucci, S. C., & Grano, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041605 · Cited by 146
The beta‐amyloid domain is essential for axonal sorting of amyloid precursor protein.
Tienari, P. J., Strooper, B. D., Ikonen, E., Simons, M., Weidemann, A., Czech, C., Hartmann, T., Ida, N., Multhaup, G., Masters, C. L., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00907.x · Cited by 148
Self-citationde Silva, H. A. R., Jen, A., Wickenden, C., Jen, L. S., Wilkinson, S. L., & Patel, A. J. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00045-4 · Cited by 172
Zinc Binding to Alzheimer's Aβ(1–16) Peptide Results in Stable Soluble Complex
Kozin, S. A., Zirah, S., Rebuffat, S., Hoa, G. H. B., & Debey, P. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5284 · Cited by 135
Wang, R., Zhang, H., & Tang, X. C. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01030-5 · Cited by 139
Schubert, D. A., & Behl, C. (1993) · Brain Research · doi:10.1016/0006-8993(93)91331-l · Cited by 147
Increased cerebrospinal fluid tau in patients with Alzheimer's disease
Jensen, M., Basun, H., & Lannfelt, L. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11297-a · Cited by 131
Refolo, L. M., Salton, S. R., Anderson, J. P., Mehta, P. D., & Robakis, N. K. R. K. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91511-8 · Cited by 129
Expression of β-Amyloid Induced Age-Dependent Presynaptic and Axonal Changes in Drosophila
Zhao, X.-L., Wang, W.-A., Tan, J.-X., Huang, J.-K., Zhang, X., Zhang, B.-Z., Wang, Y.-H., YangCheng, H.-Y., Zhu, H.-L., Sun, X.-J., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3699-09.2010 · Cited by 130
“Drosophila AD models were generated by expression of human A or APP/ presenilin/BACE ( -secretase activity of the -site APP-cleaving enzyme).”
BackgroundInfluentialDisease-modifying treatments for Alzheimer’s disease
Galimberti, D., & Scarpini, E. (2011) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285611404470 · Cited by 130
“The human APP gene was first identified in 1987, independently by several laboratories [Goldgaber et al. 1987; Kang et al. 1987; Robakis et al. 1987; Tanzi et al. 1987].”
BackgroundCSF biomarkers for Alzheimer’s disease: use in early diagnosis and evaluation of drug treatment
Blennow, K. (2005) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.5.5.661 · Cited by 130
Yoshioka, K., Miki, T., Katsuya, T., Ogihara, T., & Sakaki, Y. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91011-z · Cited by 138
Martins, R. N., Villemagne, V., Sohrabi, H. R., Chatterjee, P., Shah, T. M., Verdile, G., Fraser, P., Taddei, K., Gupta, V. B., Rainey-Smith, S. R., et al. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-171145 · Cited by 129
“A peptides are hydrophobic 39–43 amino acid long products generated by the sequential proteolytic processing of the amyloid- protein precursor (A PP) [5, 6].”
BackgroundSelf-citationVafai, S. B., & Stock, J. B. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02702-3 · Cited by 129
Uetsuki, T., Takemoto, K., Nishimura, I., Okamoto, M., Niinobe, M., Momoi, T., Miura, M., & Yoshikawa, K. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-16-06955.1999 · Cited by 129
“Briefly, full-length cDNA of human APP695 (Kang et al., 1987; Yoshikawa et al., 1992) was blunt-ended and inserted in the SwaI site of pAxCAwt cosmid (Miyake et al., 1996).”
MethodHaass, C., Koo, E. H., Capell, A., Teplow, D. B., & Selkoe, D. J. (1995) · The Journal of cell biology · doi:10.1083/jcb.128.4.537 · Cited by 129
“/3APP is encoded by a single gene on human chromosome 21 (Kang et al., 1987).”
BackgroundOyama, F., Cairns, N. J., Shimada, H., Oyama, R., Titani, K., & Ihara, Y. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62031062.x · Cited by 128
Turgeon, V. L. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00015-5 · Cited by 129
Hope, J., Multhaup, G., Reekie, L. J. D., Kimberlin, R. H., & Beyreuther, K. T. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb13883.x · Cited by 129
Self-citationLamb, B. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.9.1535 · Cited by 128
“A principal cytological hallmark of all AD cases is parenchymal deposits of β-amyloid (Aβ), a 39–43 amino acid peptide derived from APP (2).”
BackgroundThe Role and Therapeutic Targeting of α-, β- and γ-Secretase in Alzheimer's Disease
MacLeod, R., Hillert, E.-K., Cameron, R. T., & Baillie, G. S. (2015) · Future Science OA · doi:10.4155/fso.15.9 · Cited by 125
Nunan, J., Shearman, M. S., Checler, F., Cappai, R., Evin, G., Beyreuther, K., Masters, C. L., & Small, D. H. (2001) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02465.x · Cited by 127
“Ab is derived by proteolytic cleavage of the b-amyloid protein precursor (APP) [6].”
BackgroundSelf-citationRole of Phosphorylation of Alzheimer’s Amyloid Precursor Protein during Neuronal Differentiation
Ando, K., Oishi, M., Takeda, S., Iijima, K.-I., Isohara, T., Nairn, A. C., Kirino, Y., Greengard, P., & Suzuki, T. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04421.1999 · Cited by 128
“Ab is generated from a larger precursor protein, Alzheimer’s amyloid precursor protein (APP) (Goldgaber et al., 1987; Kang et al., 1987; Robakis et al., 1987; Tanzi et al., 1987, 1988; Kitaguchi et al., 1988; Ponte et al., 1988; De Sauvage and Octave, 1989), by proteolytic cleavage (for review, see…”
InfluentialLoehlin, J. C., Willerman, L., & Horn, J. M. (1988) · Annual Review of Psychology · doi:10.1146/annurev.ps.39.020188.000533 · Cited by 139
Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells
Mungenast, A. E., Siegert, S., & Tsai, L.-H. (2016) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.11.010 · Cited by 127
“Amyloid plaques are extracellular accumulations of β-amyloid (Aβ) peptides that are derived from the proteolytic processing of the βamyloid precursor protein (APP) (Goldgaber et al., 1987; Kang et al., 1987; Robakis et al., 1987; Tanzi et al., 1987).”
BackgroundPerez, R. G., Squazzo, S. L., & Koo, E. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.9100 · Cited by 105
Hardy, J. (1992) · Nature Genetics · doi:10.1038/ng0792-233 · Cited by 144
Mitochondria in Alzheimer's disease
Swerdlow, R. H., & Kish, S. J. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)53013-0 · Cited by 126
Targeting Presenilin-type Aspartic Protease Signal Peptide Peptidase with γ-Secretase Inhibitors
Weihofen, A., Lemberg, M. K., Friedmann, E., Rueeger, H., Schmitz, A., Paganetti, P., Rovelli, G., & Martoglio, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301372200 · Cited by 126
Wilhelmus, M. M. M., Boelens, W. C., Otte‐Höller, I., Kamps, B., Küsters, B., Maat–Schieman, M. L. C., de Waal, R. M. W., & Verbeek, M. M. (2006) · Acta Neuropathologica · doi:10.1007/s00401-005-0030-z · Cited by 145
hnRNP C increases amyloid precursor protein (APP) production by stabilizing APP mRNA
Rajagopalan, L. E., Westmark, C. J., Jarzembowski, J. A., & Malter, J. S. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.14.3418 · Cited by 126
Genetic linkage map of human chromosome 21
Tanzi, R. E. (1988) · Genomics · doi:10.1016/0888-7543(88)90143-7 · Cited by 125
Wirths, O., Multhaup, G., Czech, C., Feldmann, N., Blanchard, V., Tremp, G., Beyreuther, K., Pradier, L., & Bayer, T. A. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00442.x · Cited by 125
“to 42-residue A peptides (16, 37), which originate from the large precursor protein APP (29, 55).”
BackgroundSelf-citationBrioni, J. D., Esbenshade, T. A., Garrison, T. R., Bitner, S. R., & Cowart, M. (2010) · Cited by 125
Neurofibrillary tangles and β-amyloid deposits in Alzheimer's disease
Goedert, M., Sisodia, S. S., & Price, D. L. (1991) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(91)90067-h · Cited by 125
Betsholtz, C., Svensson, V., Rorsman, F., Engström, U., Westermark, G. T., Wilander, E., Johnson, K. H., & Westermark, P. (1989) · Experimental Cell Research · doi:10.1016/0014-4827(89)90407-2 · Cited by 125
Schulze, H., Schuler, A., Stüber, D., Döbeli, H., Langen, H., & Huber, G. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb13420.x · Cited by 125
Majdi, A., Sadigh-Eteghad, S., Rahigh Aghsan, S., Farajdokht, F., Vatandoust, S. M., Namvaran, A., & Mahmoudi, J. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0089 · Cited by 122
Marquez-Sterling, N. R., Lo, A. C. Y., Sisodia, S. S., & Koo, E. H. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-01-00140.1997 · Cited by 107
BEYREUTHER, K., POLLWEIN, P., MULTHAUP, G., MÖNNING, U., KÖNIG, G., DYRKS, T., SCHUBERT, W., & MASTERS, C. L. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb23035.x · Cited by 124
Self-citationIonic effects of the Alzheimer's disease β-amyloid precursor protein and its metabolic fragments
Fraser, S. P., Suh, Y.-H., & Djamgoz, M. B. A. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10079-5 · Cited by 135
Kelly, J. W., & Lansbury, P. T. (1994) · Amyloid · doi:10.3109/13506129409148451 · Cited by 147
Heterogeneity of water‐soluble amyloid β‐peptide in Alzheimer's disease and Down's syndrome brains
Russo, C., Saido, T. C., DeBusk, L. M., Tabaton, M., Gambetti, P., & Teller, J. K. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00564-4 · Cited by 123
The new biology of spongiform encephalopathy: infectious amyloidoses with a genetic twist
Brown, P., Goldfarb, L. G., & Gajdusek, D. C. (1991) · The Lancet · doi:10.1016/0140-6736(91)92670-w · Cited by 129
Developing therapeutic approaches to tau, selected kinases, and related neuronal protein targets
Lee, V. M.-Y., Brunden, K. R., Hutton, M., & Trojanowski, J. Q. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006437 · Cited by 122
Assembly, Maturation, and Trafficking of the γ-Secretase Complex in Alzheimers Disease
Dries, D., & Yu, G. (2008) · Current Alzheimer Research · doi:10.2174/156720508783954695 · Cited by 122
HAASS, C., HUNG, A. Y., SCHLOSSMACHER, M. G., OLTERSDORF, T., TEPLOW, D. B., & SELKOE, D. J. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb23037.x · Cited by 122
OTVOS, L., SZENDREI, G. I., LEE, V. M. ‐., & MANTSCH, H. H. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb19893.x · Cited by 122
“the P-amyloid precursor protein (Kang et al., 1987).”
Amyloid-β Peptide: Dr. Jekyll or Mr. Hyde?
Puzzo, D., & Arancio, O. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-129033 · Cited by 118
Syková, E., Voříšek, I., Antonova, T., Mazel, T., Meyer-Luehmann, M., Jucker, M., Hájek, M., Or, M., & Bureš, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408235102 · Cited by 121
Pierrot, N., Santos, S. F., Feyt, C., Morel, M., Brion, J.-P., & Octave, J.-N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606015200 · Cited by 121
Neural Transplantation in Animal Models of Dementia
Dunnett, S. B. (1990) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1990.tb00448.x · Cited by 123
The PreA4695precursor protein of Alzheimer's disease A4 amyloid is encoded by 16 exons
Lemaire, H. G., Salbaum, J. M., Multhaup, G., Kang, J., Bayney, R. M., Unterbeck, A., Beyreuther, K., & Muller-Hill, B. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.2.517 · Cited by 121
Self-citationGenome instability in Alzheimer disease
Hou, Y., Song, H., Croteau, D. L., Akbari, M., & Bohr, V. A. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.04.005 · Cited by 120
“Under normal conditions, APP is processed to produce APPsα, AICD and p3 by α-secretase followed by γ-secretase, in a non-amyloid pathway, but under pathological conditions, APP is cleaved by β-secretase followed by γ-secretase to form Aβ40 and Aβ42, which then aggregate to form Aβ oligomers and fibrils (Haass and Stei…”
Background
Metadata
- Authors
- Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B.
- Affiliations
- University of Cologne (DE)
- Venue
- Nature
- Published
- 1987-02
- Volume
- 325
- Issue
- 6106
- Pages
- 733-736
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2081881251
- Cited by
- 4,619
- References
- 26
- Citations by year
- 2026: 38 · 2025: 58 · 2024: 63 · 2023: 71 · 2022: 54 · 2021: 79 · 2020: 82 · 2019: 76 · 2018: 76 · 2017: 98 · 2016: 111 · 2015: 90 · 2014: 97 · 2013: 119 · 2012: 126
- FWCI
- 164.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid precursor protein, cell surface receptors, Down syndrome, amyloid plaques, neurofibrillary tangles, chromosome 21, cDNA cloning, protein sequences
- MeSH terms
- Alzheimer Disease, Amyloid, Base Sequence, Brain, Brain Chemistry, Chromosomes, Human, Pair 21, DNA, Down Syndrome, Fetus, Humans, Neurofibrils, Nucleic Acid Hybridization, Protein Precursors, Protein Processing, Post-Translational, RNA, Messenger, Amyloid beta-Peptides, Amyloid beta-Protein Precursor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.